Can sertraline (generic) cause peripheral neuropathy presenting as burning feet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Sertraline Cause Burning Feet?

No, sertraline is not a recognized cause of peripheral neuropathy or burning feet syndrome. Sertraline does not appear in any established lists of neurotoxic medications that cause drug-induced peripheral neuropathy.

Evidence Against Sertraline as a Cause

  • Comprehensive reviews of drug-induced peripheral neuropathy identify chemotherapeutic agents (platinum compounds, vinca alkaloids, taxanes), antimicrobials, cardiovascular drugs, psychotropic medications, and anticonvulsants as the primary culprits—but selective serotonin reuptake inhibitors (SSRIs) like sertraline are notably absent from these lists. 1, 2

  • The major medication classes causing peripheral neuropathy include antineoplastic agents, antiretroviral nucleoside reverse transcriptase inhibitors, alpha-interferon, statins, tacrolimus, metronidazole, dapsone, nitrofurantoin, colchicine, and thalidomide—sertraline is not among them. 3

  • When sertraline is mentioned in clinical guidelines, it appears only as a treatment for neuropathic symptoms (specifically hepatic pruritus at 75–100 mg daily), not as a cause of neuropathy. 4

Alternative Explanations for Burning Feet

Burning feet syndrome is a classic manifestation of small-fiber neuropathy, which has well-established causes unrelated to sertraline:

  • Diabetes mellitus is the most common cause of peripheral neuropathy worldwide, affecting approximately 206 million people and accounting for more than 50% of neuropathy cases in Western populations. The presentation includes burning pain, altered temperature sensation, and abnormal pinprick perception in a symmetric "glove-and-stocking" distribution. 5, 6

  • Vitamin B12 deficiency causes peripheral neuropathy with numbness and tingling; patients on long-term metformin (especially ≥2 g daily) are at particular risk. 7

  • Other neurotoxic medications to review include chemotherapy agents (cisplatin, paclitaxel, vincristine), amiodarone, HIV medications (stavudine, zalcitabine), and alcohol. 5, 6

  • Systemic diseases such as hypothyroidism, renal insufficiency, HIV infection, hepatitis C, and autoimmune rheumatologic conditions predispose to neuropathy. 6, 7

Recommended Diagnostic Approach

  • Check fasting glucose and HbA1c to exclude diabetic neuropathy, which is the leading cause of burning feet. 7

  • Measure serum B12 with metabolites (methylmalonic acid ± homocysteine) to identify reversible vitamin deficiency. 5

  • Obtain serum protein electrophoresis with immunofixation to screen for monoclonal gammopathies. 5

  • Review all current medications for known neurotoxic agents, focusing on chemotherapy, antiretrovirals, and other drugs listed above—not sertraline. 6, 7

  • Perform a focused neurologic examination including 10-g monofilament testing, pinprick sensation, vibration sense with 128-Hz tuning fork, and ankle reflexes to characterize the neuropathy pattern. 7

Management of Neuropathic Pain

  • Duloxetine 30 mg daily for one week, then 60 mg daily, is first-line therapy for neuropathic pain, providing 30–50% pain reduction. 7, 5

  • Alternative agents include pregabalin, gabapentin (1200 mg daily achieves ≥50% pain reduction in 38% of patients with painful diabetic neuropathy), tricyclic antidepressants, or venlafaxine. 5, 7

  • Structured physical activity programs improve neuropathic symptoms and functional status. 7

References

Research

Drug-Induced Peripheral Neuropathy: A Narrative Review.

Current clinical pharmacology, 2020

Research

[Neurotoxic effects of medications: an update].

Revue medicale de Liege, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cyclosporine‑Induced Peripheral Neuropathy in Aplastic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Differential Diagnoses for Generalized Numbness and Tingling

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.